Form 4: Molina Healthcare Director Receives Equity Grant
Insider Transaction Report
Molina Healthcare Director Steven J. Orlando was granted 317 shares of common stock as part of his director compensation plan.
Summary
- Steven J. Orlando, a Director of Molina Healthcare, Inc. (MOH), acquired 317 shares of common stock.
- The transaction occurred on January 1, 2026, as part of the Issuer's 2025 Equity Incentive Plan.
- The shares were granted in connection with Mr. Orlando's services as a Director.
- The grant value was calculated based on the closing price of $173.54 per share on December 31, 2025, as January 1, 2026, was a non-trading day.
- The aggregate dollar value of this quarterly equity award was $55,000, representing one-quarter of the annual $220,000 director equity award.
- Following this transaction, Mr. Orlando beneficially owns 17,325 shares indirectly through the Orlando Family Trust and 1,500 shares indirectly through his 401(k) plan.
Sentiment
Score: 6
Explanation: The filing reports a routine equity grant to a director, which is a positive for aligning management and shareholder interests, but not a significant market-moving event.
Positives
- The acquisition of shares by a director increases their beneficial ownership, aligning their interests with those of shareholders.
- The equity grant is part of a pre-established compensation plan, indicating a structured approach to director remuneration.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Update | Steven Orlando granted a Limited Power of Attorney to Jeff D. Barlow and Codruta Catanescu, authorizing them to execute and file Forms 3, 4, and 5 on his behalf. This revokes a previous Power of Attorney from November 8, 2005. | 02/16/2011 | Streamlines the process for insider transaction filings for Steven Orlando, ensuring timely compliance with Section 16(a) of the Securities Exchange Act of 1934. |
Related Party Transactions
- 17,325 shares of common stock are held indirectly by the Orlando Family Trust, a related party to Steven J. Orlando.
Stakeholder Impact
- Shareholders: The equity grant aligns the director's financial interests with the company's performance, potentially encouraging decisions that benefit long-term shareholder value.
Key Dates
| Date | Description |
|---|---|
| 11/08/2005 | Previous Limited Power of Attorney granted to Jeff D. Barlow and Mark L. Andrews was revoked. |
| 02/16/2011 | Limited Power of Attorney granted to Jeff D. Barlow and Codruta Catanescu by Steven Orlando. |
| 12/31/2025 | Closing price of Molina Healthcare common stock ($173.54) used to calculate the number of shares for the equity grant. |
| 01/01/2026 | Transaction date for the acquisition of 317 shares of common stock by Steven J. Orlando. |
| 01/02/2026 | Signature date of the Form 4 filing by Jeff D. Barlow, by power of attorney for Steven J. Orlando. |
Keywords
Molina Healthcare, MOH, Steven J. Orlando, Director Compensation, Equity Grant, Insider Transaction, Form 4, Stock Award, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.